Dexamethasone in Reducing Everolimus-Induced Oral Stomatitis in Patients With Cancer
This phase III trial studies how well dexamethasone works in reducing everolimus-induced oral stomatitis in patients with cancer. Dexamethasone may help to reduce the everolimus-induced oral stomatitis so as to improve quality of life in cancer patients.
Research Base:Alliance for Clinical Trials in Oncology
NCT ID: NCT03839940
NCI Protocol Number: A221701
Status: Recruiting
For more information see ClinicalTrials.gov
Interventions
- Everolimus
- Quality-of-Life Assessment
- Questionnaire
- Placebo
- Dexamethasone
Condition
Malignant Neoplasm
Trial Type
Supportive Care/Symptom Management/PROs
See a list of participating sites on ClinicalTrials.gov